Description: Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Home Page: www.divislabs.com
Divi Towers
Hyderabad,
500032
India
Phone:
91 40 6696 6300
Officers
| Name | Title |
|---|---|
| Dr. Kiran Satchandra Divi B. Pharm., M.Pharm | CEO & Whole-Time Director |
| Mr. Venkata Ramana Nimmagadda B.Sc.(Chem) | Executive Director |
| Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D. | MD & Executive Director |
| Dr. Devendra Rao Sureddy M.Sc. | Whole-Time Director (Manufacturing) |
| Ms. Nilima Prasad Divi | Whole-time Director, Chief Control Officer & Director of Commercial |
| Mr. L. Kishore Babu B.Com, FCMA, FICWA | Chief Financial Officer |
| Mr. L. Ramesh Babu LLB, M.Com, MBA | VP of Procurement & Chief Information Officer |
| Mr. M. Satish Choudhury | Company Secretary & Compliance Officer |
| Mr. Satya Prakash Divi B.Tech (Mech), MBA, MS (CIS) | Vice President of Sales, Marketing & Logistics |
| Mr. Y. T. S. Prasad B.E. | Global Quality Head |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 88.4924 |
| Price-to-Book MRQ: | 11.865 |
| Price-to-Sales TTM: | 18.904 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 9741 |